ArticleTropical diseases, travel medicine and vaccines2025
GenoDense-Net: unraveling the genomic puzzle of the global pathogen.
Article in Tropical diseases, travel medicine and vaccines, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The respiratory system of humans is impacted by infectious and deadly illnesses like COVID-19. Early identification and diagnosis of this type of illness is essential to stop the infection from spreading further. In the present research, we presented a technique for determining the condition using COVID-19's current genome sequences employing the DenseNet-16 framework. We operated a network of already trained neurons before using a transfer learning method to prepare it according to our dataset. Additionally, we preprocessed the collected information using the NearKbest interpolation approach; then, we utilized Adam Optimizer to optimize our findings. Compared with special deep learning models like ResNet-50, VGG-19, AlexNet, and VGG-16, our approach produced an accuracy of 99.18%. The model was deployed on a platform with GPU support, which greatly decreased training time. Dataset size and the requirement for further validation are two of the study's limitations, despite the encouraging results. The current research showed how a deep learning approach may be useful to categorize the genome sequence of infectious disease like COVID-19 using the suggested GenoDense-Net architecture. The next step in this research project is conducting investigations in the clinic.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.